LENZ Therapeutics, Inc. (LENZ) Revenue (2025 - 2026)

LENZ Therapeutics (LENZ) posted quarterly Revenue of $1.9 million for Q1 2026, up 115.21% sequentially from -$12.5 million in Q4 2025.

LENZ Therapeutics, Inc. (LENZ) Revenue (2025 - 2026) Analysis & Trends

LENZ Therapeutics has disclosed Revenue across 2 years of filings, most recently posting $1.9 million for Q1 2026.

In Q1 2026, Revenue changed N/A year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $6.9 million (changed N/A YoY), while the FY2025 annual figure was $5.0 million, changed N/A from the prior year.
Revenue advanced to $1.9 million in Q1 2026, from -$12.5 million in the prior quarter.
Over the last five years, Revenue for LENZ reached as high as $12.5 million in Q3 2025 and fell as low as -$12.5 million in Q4 2025.

Download Data